Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +54.31%
#2 Pons Pons +47.16%
#3 TENDIES TENDIES +38.82%
#4 PondCoin PondCoin +38.73%
#5 Magma Finance Magma Finance +33.15%
#6 Ocean Protocol Ocean Protocol +31.27%
#7 Purr Purr +30.67%
#8 The Bitcoin Bull The Bitcoin Bull +28.58%
#9 StonkBroker StonkBroker +27.84%
#10 Starpower Starpower +27.48%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
Rang in Aktien #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Aktienkurs
$1.05
Marktkapitalisierung
$25.12M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-86.83%
Land
US
Handel Actuate Therapeutics Inc (ACTU)

Kategorie

Healthcare
EPS für Actuate Therapeutics Inc (ACTU)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Actuate Therapeutics Inc beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Actuate Therapeutics Inc von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH